Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
…
continue reading
Experts at Queen Mary University of London
…
continue reading
Magic comes to Mile End with Brent Morris, Arthur Benjamin and Colm Mulcahy.
…
continue reading
This is a podcast from the Centre for the History of Emotions at Queen Mary, University of London. 'The Sound of Anger' won two gold British Podcast Awards in 2020. Subscribe on Apple Podcasts via iTunes here: https://itunes.apple.com/gb/podcast/living-with-feeling/id1186251350?mt=2
…
continue reading
Queen Mary, University of London is one of the UK's leading research-focused higher education institutions. With around 16,900 students and 3,800 staff, we are one of the biggest University of London colleges. We teach and research across a wide range of subjects in the humanities, social sciences, law, medicine and dentistry, and science and engineering. Based in a creative and culturally diverse area of east London, we are the only London university able to offer a completely integrated re ...
…
continue reading
Experts on Camera
…
continue reading
Young journalists from The Print (the student newspaper of Queen Mary University of London), discuss issues affecting students in this podcast.
…
continue reading
Internal launch of the life sciences initiative
…
continue reading

1
David Willetts MP, Inaugural John Ramsden Memorial Lecture: Liberal Conservatism
Queen Mary, University of London
What can Liberal Conservatism do for you? The Seventy-Sixth Mile End Group event was given by David Willetts MP on the nature of Liberal Conservatism. David Linsay Willetts (born 9 March 1956) is a British Conservative Party politician and the Minister of State for Universities and Science. He is the Member of Parliament (MP) representing the constituency of Havant in Hampshire. This memorial lecture is a tribute to the life and work of John Ramsden, an eminent historian, politician and memb ...
…
continue reading

1
Professor Joseph Nye, The 2nd Michael Quinlan Lecture: What is Ethical Foreign Policy Leadership?
Queen Mary, University of London
How can we decide what is appropriate in the sphere of global politics? Prof. Joseph Nye, eminent academic, author, and politician with expertise in the field of foreign policy, defense, diplomacy and terrorism talks about his experiences within foreign policy and how he has come to his conclusions using examples like the Iraq war and nuclear weapons. For more information go to www.meg.qmul.ac.uk.
…
continue reading
…
continue reading
What makes a prolific political figure tick? Alastair John Campbell (born 25 May 1957) is a British journalist, broadcaster, political aide and author, best known for his work as Director of Communications and Strategy for Prime Minister Tony Blair between 1997 and 2003. In this interview from 20th June at Mile End Group, Alastair explores his recent autobiography, recounting the key parts of his, and Tony Blair's, career in politics, from the Iraq war to 9/11, and even the Premier's relatio ...
…
continue reading

1
Today's Neuroscience, Tomorrow's History - Professor Geoffrey Burnstock
Professor Geoffrey Burnstock
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Burnstock returned to London in 1975, becoming Head of Department of Anatomy and Developmental Biology at University College London and ...
…
continue reading
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Roger Ordidge studied physics at the University of Nottingham, and went on to obtain his PhD in 1981 under the supervision of Professor ...
…
continue reading
Strategies for Bending Time in Music
…
continue reading
Professor Jack Cuzick discusses IBIS-I breast cancer research
…
continue reading

1
Study undergraduate medicine in Malta with a top UK medical school
Queen Mary University of London
…
continue reading

1
Today's Neuroscience, Tomorrow's History - Professor Elizabeth Warrington
Professor Elizabeth Warrington
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Elizabeth Warrington completed her PhD on visual processing at the Institute of Neurology, London, and was formerly head of the Departme ...
…
continue reading
In this video, we see that mice that are given toys and placed in stimulating surroundings have healthier immune systems.
…
continue reading

1
Episode 408: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC
47:27
47:27
Play later
Play later
Lists
Like
Liked
47:27Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting
…
continue reading

1
Episode 407: Uromigos Japan - European Delphi Study of mRCCについてdiscussion
33:04
33:04
Play later
Play later
Lists
Like
Liked
33:04今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました!!
…
continue reading

1
Episode 407: Drug Development in China: Part 2 of 2
25:21
25:21
Play later
Play later
Lists
Like
Liked
25:21Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China
…
continue reading

1
Episode 406: Drug Development in China: Part 1 of 2
30:02
30:02
Play later
Play later
Lists
Like
Liked
30:02Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.
…
continue reading

1
Episode 405: The Good News About Cancer podcast
17:53
17:53
Play later
Play later
Lists
Like
Liked
17:53Drs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.
…
continue reading

1
Episode 404: 177 Lu-PSMA Pre-chemotherapy in mCRPC. Final Podcast from the Canary Islands
27:09
27:09
Play later
Play later
Lists
Like
Liked
27:09Elena Castro joins Tom and Brian on the day after Pluvicto approval pre-chemotherapy in the US to discuss the PSMA Fore data and application in clinical practice.
…
continue reading

1
Episode 403: ADCs in Bladder Cancer. Part 2 from the Canary Islands
37:41
37:41
Play later
Play later
Lists
Like
Liked
37:41Ignacio Duran continues his discussion with Brian and Tom regarding novel ADCS in bladder cancer
…
continue reading

1
Episode 402: Uromigos en Espanol: Futuro del carcinoma de células renales
25:12
25:12
Play later
Play later
Lists
Like
Liked
25:12Cristina Suárez analiza los próximos ensayos clínicos que podrían transformar el manejo del cáncer renal en los próximos años: nuevas combinaciones adyuvantes y estrategias perioperatorias, el uso de tripletes enprimera línea y la integración de inhibidores de HIF con TKIs, entre otros.
…
continue reading

1
Episode 401: ADCs in Bladder Cancer. Part 1 from the Canary Islands
30:29
30:29
Play later
Play later
Lists
Like
Liked
30:29Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
…
continue reading

1
Episode 400: The Uromigos Score for Urothelial Cancer
20:19
20:19
Play later
Play later
Lists
Like
Liked
20:19Live from the Canary Islands 'Big Idea' talk from Tom, we discuss the new Uromigos Score which ranks different treatment options in several urothelial cancer settings.
…
continue reading

1
Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?
36:44
36:44
Play later
Play later
Lists
Like
Liked
36:44Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.
…
continue reading

1
Episode 398: Reflections on the Felix Feng Symposium at ASCO GU
32:05
32:05
Play later
Play later
Lists
Like
Liked
32:05Chuck Ryan joins us to discuss his interview with Felix and reflects on his keynote address at ASCO GU 2025.
…
continue reading

1
Episode 397: APCCC Diagnostics Conference recap
43:15
43:15
Play later
Play later
Lists
Like
Liked
43:15Silke Gillessen joins us to discuss the top areas of consensus and controversy from APCCC 2025
…
continue reading
尿路上皮癌と腎癌の臨床に影響を与えるエビデンスをどう解釈するか!?
…
continue reading

1
Episode 395: Uromigos Japan: ASCO GU 2025のレビュー
31:24
31:24
Play later
Play later
Lists
Like
Liked
31:24ASCOGU2025で発表された臨床試験の結果の解釈について忖度なしに議論しました!!
…
continue reading

1
Episode 394: APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025
30:27
30:27
Play later
Play later
Lists
Like
Liked
30:27Tyler Seibert from UCSD joins the show live from Lugano to discuss meeting highlights and controversies (and his favorite run along the water..)
…
continue reading
Silke joins Tom and Brian to discuss highlights form ASCO GU 2025
…
continue reading

1
Episode 392: ASCO GU 2025 - HIF Inhibition with Casdatifan in Refractory RCC
30:09
30:09
Play later
Play later
Lists
Like
Liked
30:09Toni Choueiri discusses the updated data from different cohorts of this novel HIF inhibitor.
…
continue reading

1
Episode 391: ASCO GU 2025 - KIM-1 Data from Checkmate 214
23:28
23:28
Play later
Play later
Lists
Like
Liked
23:28Vincent Xu discusses this emerging RCC biomarker and data from the Checkmate 214 trial
…
continue reading

1
Episode 390: ASCO GU 2025 - Pembro-based Doublets in Refractory RCC and COSMIC-313 OS Update
30:03
30:03
Play later
Play later
Lists
Like
Liked
30:03Laurence Albiges joins the show to discuss novel combos in refractory RCC and an update of the Ipi/Nivo/Cabo COSMIC OS data
…
continue reading

1
Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer
25:28
25:28
Play later
Play later
Lists
Like
Liked
25:28Gopa Iyer from MSKCC joins the show to discuss his initial results from this phase 2 trial.
…
continue reading

1
Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results
27:07
27:07
Play later
Play later
Lists
Like
Liked
27:07Xinan Sheng. M.D., Professor in the Department of Genitourinary Oncology at Peking University Cancer Hospital &institute in Beijing, China joins us to discuss the update of this trial and impressive pCR rates.
…
continue reading

1
Episode 389: ASCO GU 2025 - NIAGARA Pathologic CR Updates and Outcomes
28:23
28:23
Play later
Play later
Lists
Like
Liked
28:23Matt Galsky joins the show to discuss pCR in NIAGARA and clinical implications.
…
continue reading

1
Episode 386: ASCO GU 2025 - APRI Meta-analysis
28:58
28:58
Play later
Play later
Lists
Like
Liked
28:58Tanya Dorff from City of Hope joins us to discuss clinical implications of these data and also comment on TALAPRO-2
…
continue reading
Neeraj Aggarwal joins Tom and Brian for an in-depth look at these important data
…
continue reading
Silke Gillessen joins Brian and Tom and they discuss what to look forward to in prostate, bladder and RCC at ASCO GU 2025.
…
continue reading

1
Episode 383: A Neoantigen Vaccine Generates Anti-tumor Immunity in RCC
33:11
33:11
Play later
Play later
Lists
Like
Liked
33:11David Braun joins the show to discuss his Nature paper on a personalized RCC vaccine
…
continue reading

1
Episode 382: Uromigos Japan - TROPICs-04の考察
29:48
29:48
Play later
Play later
Lists
Like
Liked
29:48残念ながらNegative StudyとなったTROPICs-04についてUromigosJapanの3人が忖度なしに、その原因や理由について考察をします!!
…
continue reading

1
Episode 381: Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
40:05
40:05
Play later
Play later
Lists
Like
Liked
40:05Romain Banchereau joins the show to discuss and debate this Cancer Cell paper on molecular subtypes in urothelial cancer and implications for checkpoint blockade.
…
continue reading
Shankar Siva joins the show to discuss the emerging role of stereotactic body radiotherapy (SBRT) in primary and metastatic RCC tumors.
…
continue reading

1
Episode 379: Uromigos Japan: 2024年のGU Oncologyを振り返る
31:31
31:31
Play later
Play later
Lists
Like
Liked
31:313人による2024年のGU oncoloyのレビューを切れ味鋭く解説しています。乞うご期待!
…
continue reading

1
Episode 378: 2025 Preview of Important GU Data
41:42
41:42
Play later
Play later
Lists
Like
Liked
41:42Tanya Dorff from City of Hope joins Brian and Tom to review what to expect throughout 2025 and beyond in terms of clinically impactful data in prostate, renal and bladder cancer
…
continue reading

1
Episode 377: Prostate Cancer 2024 Highlights
35:12
35:12
Play later
Play later
Lists
Like
Liked
35:12Silke Gilleson gives Tom and Brian 3 'gifts': Thomas Zilli (Radiation Oncology), Jochen Walz (Urology) and Ken Hermann (Nuclear Medicine) who discuss the 2024 prostate highlights from each of their unique perspectives.
…
continue reading

1
Episode 376: Bladder Cancer 2024 Highlights
25:37
25:37
Play later
Play later
Lists
Like
Liked
25:37Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer form the past year.
…
continue reading

1
Episode 375: Renal Cancer 2024 Highlights
43:11
43:11
Play later
Play later
Lists
Like
Liked
43:11David McDermott (and his dog, Finn) join the show to review the top data from 2024 in RCC
…
continue reading

1
Episode 374: Mechanisms of HIF Resistance
34:37
34:37
Play later
Play later
Lists
Like
Liked
34:37Jim Brugarolas joins to discuss his talk from IKCS 2024 and the board topic of resistance to HIF inhibitors.
…
continue reading

1
Episode 373: KEYNOTE-564 Asian OSとANNARの解説
34:05
34:05
Play later
Play later
Lists
Like
Liked
34:05JSCO2024で発表されたKEYNOTE-564東アジア人OSデータとANNAR biomarker studyの解説とディスカッションです
…
continue reading

1
Episode 372: FDA Accelerated Approval Process
31:30
31:30
Play later
Play later
Lists
Like
Liked
31:30Dan Suzman from FDA joins us to discuss the Accelerated Approval process, requirements, successes and challenges.
…
continue reading

1
Episode 371: TROPICS-04 Results from ESMO Asia
33:43
33:43
Play later
Play later
Lists
Like
Liked
33:43Jonathan Rosenberg joins Brian and Tom to discuss this important phase 3 trial and efficacy and toxicity signals.
…
continue reading

1
Episode 370: Artificial Intelligence in Medical Oncology
44:46
44:46
Play later
Play later
Lists
Like
Liked
44:46Jacob Kather joins Brian and Tom to discuss emerging AI applications in Oncology
…
continue reading

1
Episode 369: Paper of the Month with Bishoy Faltas
45:51
45:51
Play later
Play later
Lists
Like
Liked
45:51Bishoy joins us to discuss his work on extrachromosomal DNA in bladder cancer from his latest Nature publication
…
continue reading

1
Episode 368: Radiomics in RCC: Live from IKCS
37:00
37:00
Play later
Play later
Lists
Like
Liked
37:00Andrew Smith from St. Jude's joins us to discuss the emerging field of radiomics and shares his hopes and skepticism
…
continue reading

1
Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer
56:48
56:48
Play later
Play later
Lists
Like
Liked
56:48Chuck Ryan from MSKCC joins to talk about various aspects of AR inhibition in prostate cancer and relative benefits and risks.
…
continue reading

1
Episode 366: ARPIs in Prostate Cancer - Are They Different?
31:51
31:51
Play later
Play later
Lists
Like
Liked
31:51Chris Sweeney and Rob Jones join Brian and Tom to discuss the relative merits of different ARPIs in prostate cancer.
…
continue reading

1
Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC)
47:59
47:59
Play later
Play later
Lists
Like
Liked
47:59Episode 365: Silke Gillessen and Betrand Tombal join the show to discuss the APCCC meeting and recent publication.
…
continue reading

1
Episode 364: 腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜
15:41
15:41
Play later
Play later
Lists
Like
Liked
15:41腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜
…
continue reading

1
Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
14:23
14:23
Play later
Play later
Lists
Like
Liked
14:23前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
…
continue reading
膀胱がんの最新の話題〜周術期薬物療法とADC〜
…
continue reading

1
Episode 361: The Role of Monotherapy AR Inhibition in Prostate Cancer
25:43
25:43
Play later
Play later
Lists
Like
Liked
25:43Betrand Tombal joins Brian and Tom to discuss the historic and current data for AR inhibition with monotherapy with AR blockers.
…
continue reading

1
Episode 360: The SUNRISE Program in Bladder Cancer
46:19
46:19
Play later
Play later
Lists
Like
Liked
46:19Christopher Cutie from J&J joins the show to discuss the SUNRISE bladder program with the gemcitabine-eluting pretzel across several NMIBC and MIBC states.
…
continue reading